Biogen Inc. (BIIB)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
312.58-2.23 (-0.71%)
At close: 4:00 PM EDT
People also watch:
CELGGILDREGNAMGNALXN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open312.58
Prev Close314.81
Bid311.00 x 100
Ask319.00 x 100
Day's Range312.11 - 317.32
52wk Range223.02 - 333.65
1y Target EstN/A
Market Cap68.49B
P/E Ratio (ttm)18.26
Beta0.40
Volume783,352
Avg Vol (3m)1,828,503
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • The Wall Street Journal21 hours ago

    [$$] Rodin Therapeutics, a Neurology Drug Firm, Expands Management Team

    Venture-backed neurological drug developer Rodin Therapeutics Inc. said it has expanded its leadership team and advisory boards as it advances brain-penetrant drug candidates toward clinical trials.

  • Capital Cubeyesterday

    Top 5 profitable Biotech stocks : September 23, 2016

    Categories: Yahoo Finance Symbol Company Fundamental Analysis Score Net Profit Margin (%) One Month Share Price Performance GILD-US Gilead Sciences, Inc. 84 50.83 0.74 BIIB-US Biogen Inc. 81 37.35 -0.63 AMGN-US Amgen Inc. 53 33.46 0.73 ALIOF-US Actelion Ltd. 64 28.27 2.65 ILMN-US Illumina, Inc. 97 18.77 3.22 GILD-US‘s share price performance of -23.46% over the last 12 ... Read more (Read more...)

  • Investopedia2 days ago

    Biogen Bets on Nusinersen (BIIB, IONS)

    Biogen’s SMA drug nusinersen can emerge as a big winner in the mid- to long-term.